3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Neoplasm Metastasis
6
Ovarian Neoplasms
5
Endometrial Neoplasms
5
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms by Site
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Diseases
2
Uterine Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Melanoma
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Genital Neoplasms, Female
1
Genetic Diseases, Inborn
1
Fallopian Tube Neoplasms
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Lobular
1
Interventions
Cyclophosphamide
12
Rituximab
10
obinutuzumab
6
fludarabine phosphate
6
Prednisone
6
fludarabine
5
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Melphalan
5
Magnetic Resonance Spectroscopy
5
Lenalidomide
5
Etoposide
5
Biopsy
5
tocilizumab
4
ibrutinib
4
Whole-Body Irradiation
4
Doxorubicin
4
venetoclax
3
polatuzumab vedotin
3
glofitamab
3
Mycophenolic Acid
3
Leukapheresis
3
Filgrastim
3
Cytarabine
3
Cyclosporine
3
Busulfan
3
Bendamustine Hydrochloride
3
ulixertinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
Fulvestrant
×
30 days
×
Clear all
No trials found.